amiodarone has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 2 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lakatos, P | 1 |
| Beghi, E | 1 |
| Simone, P | 1 |
| Apollo, F | 1 |
| Di Viesti, P | 1 |
| Treviso, M | 1 |
| Tonali, P | 1 |
2 other studies available for amiodarone and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
[Editor's commentary. Advances in endocrinology].
Topics: Amiodarone; Anti-Arrhythmia Agents; Diabetic Neuropathies; Endocrine System Diseases; Female; Humans | 2013 |
Polyneuropathy in an adult hospital population. Assessment of the prevalence through a simple screening procedure.
Topics: Adolescent; Adult; Age Factors; Aged; Amiodarone; Child; Diabetic Neuropathies; Epidemiologic Method | 1988 |